MA
About
Michael Aberman, M.D. joined Regeneron in 2010 as Vice President, Strategy and Investor Relations. Prior to joining Regeneron, Dr. Aberman was a Wall Street research analyst covering the biotechnology industry in positions at Credit Suisse and Morgan Stanley. Before moving to Wall Street, Dr. Aberman was Director of Business Development at Antigenics, Inc., an oncology-focused biotechnology company. Dr. Aberman received his medical degree from the University of Toronto, completed residency training in Internal Medicine at New York Presbyterian Hospital/Weill Cornell Medical Center, and received his M.B.A. from The Wharton School of Business.
Position in the VCSift Database
- • 2 investors hold the Interim Chief Business Officer role in VCSift. Michael Aberman is one of them.
- • 10,621 investors are based in New York, New York, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- New York, US
Contact Information
linkedin.com/in/••••••••
Find more investors like Michael
Search Investors